Genetic backgrounds and diagnosis of familial hypercholesterolemia
Joanna Rogozik, Renata Główczyńska, Marcin Grabowski
Abstract
Lipid disorders play a critical role in the intricate development of atherosclerosis and its clinical consequences, such as coronary heart disease and stroke. These disorders are responsible for a significant number of deaths in many adult populations worldwide. Familial hypercholesterolemia (FH) is a genetic disorder that causes extremely high levels of LDL cholesterol. The most common mutations occur in genes responsible for low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), or proprotein convertase subtilisin/kexin type 9 (PCSK9). While genetic testing is a dependable method for diagnosing the disease, it may not detect primary mutations in 20%-40% of FH cases.
Topics & Concepts
PCSK9Familial hypercholesterolemiaKexinApolipoprotein BLDL receptorProprotein convertaseGenetic disorderMedicineDiseaseGeneticsInternal medicineLipoproteinCholesterolBiologyBioinformaticsLipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismDiabetes, Cardiovascular Risks, and Lipoproteins